Free tool
FAERS Monitor: Flovent Diskus 250
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020833 or its brand name (Flovent Diskus 250, Fluticasone Propionate). Reports on generic versions are filed under their own applications.
Reports
30,966
Serious
17,995
58% of reports
Hospitalization
8,091
Death reported
1,765
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea2,500
- drug ineffective2,452
- headache2,353
- fatigue2,173
- off label use1,942
- pain1,915
- nausea1,881
- cough1,807
- asthma1,684
- diarrhoea1,667
- product dose omission issue1,518
- pneumonia1,477
- dizziness1,436
- malaise1,275
- vomiting1,240
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 383 |
| 2005 | 329 |
| 2006 | 341 |
| 2007 | 414 |
| 2008 | 430 |
| 2009 | 383 |
| 2010 | 584 |
| 2011 | 918 |
| 2012 | 1,016 |
| 2013 | 372 |
| 2014 | 484 |
| 2015 | 1,120 |
| 2016 | 1,530 |
| 2017 | 1,239 |
| 2018 | 1,698 |
| 2019 | 1,718 |
| 2020 | 2,072 |
| 2021 | 1,883 |
| 2022 | 2,236 |
| 2023 | 2,733 |
| 2024 | 3,322 |
| 2025 | 3,319 |
| 2026 | 2,441 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,023,193 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| asthmaSignal | 1,684 | 10.3 | 9.8 | 13,928 |
| coughSignal | 1,807 | 4.4 | 4.2 | 4,775 |
| product dose omission issueSignal | 1,518 | 3.5 | 3.4 | 2,760 |
| pneumoniaSignal | 1,477 | 3.1 | 3.0 | 2,133 |
| dyspnoeaSignal | 2,500 | 3.0 | 2.9 | 3,428 |
| headacheSignal | 2,353 | 2.6 | 2.5 | 2,285 |
| painSignal | 1,915 | 2.1 | 2.0 | 1,164 |
| malaise | 1,275 | 2.0 | 1.9 | 626 |
| dizziness | 1,436 | 2.0 | 1.9 | 687 |
| fatigue | 2,173 | 1.9 | 1.8 | 956 |
| vomiting | 1,240 | 1.8 | 1.7 | 443 |
| diarrhoea | 1,667 | 1.8 | 1.7 | 558 |
| nausea | 1,881 | 1.6 | 1.5 | 457 |
| off label use | 1,942 | 1.5 | 1.4 | 345 |
| drug ineffective | 2,452 | 1.3 | 1.2 | 144 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.